Inhaler Technology

Recent advances in capsule-based dry powder inhaler technology

Pulmonary drug delivery is currently the focus of accelerated research and development because of the potential to produce maximum therapeutic benefit to patients by directly targeting drug to the site of pathology in the lungs. Among the available delivery options, the dry powder inhaler (DPI) is the preferred device for the treatment of an increasingly diverse range of diseases. However, beca...

MAXIFLO Inhaler

MAXIFLO-125 Inhaler Each actuation delivers: Formoterol Fumarate Dihydrate IP..................6 mcg Fluticasone Propionate IP............................125 mcg Suspended in propellant HFA 134a ...............q.s. MAXIFLO-250 Inhaler Each actuation delivers: Formoterol Fumarate Dihydrate IP .................6 mcg Fluticasone Propionate IP...........................250 mcg Suspended in propella...

Chloroform Inhaler

Gailey's 1895 anesthetic inhaler.

Subanesthetic concentrations of desflurane and propofol suppress recall of emotionally charged information. alpha 4 subunit knockout mice are resistant to the amnes-tic effect of isoflurane. suppresses stress-enhanced fear learning in a rodent model of post-traumatic stress disorder. After receiving his B.S. from Michigan Agricultural College and then pursuing preliminary medical studies in Mic...

Erratum to: Recent advances in capsule-based dry powder inhaler technology

[This corrects the article DOI: 10.1186/s40248-017-0092-5.].